Drug developer rattles tin for another cash dollop
MELBOURNE: Neurological diseases drug development company Actinogen Medical, capitalised at $95 million on the ASX,
MELBOURNE: Neurological diseases drug development company Actinogen Medical, capitalised at $95 million on the ASX,
FEATURED
Bank to support housing for seniors and people with disability
Multigenerational housing makes comeback as market conditions improve
New research confirms dementia growth in all generations
Boomer turned 1000 straw bales into a fortress-like house
Virtual reality deployed to support assisted living residents
Best affordable seniors housing design for Global Awards shortlisted
INNOVATION
